About XYIRIS PHARMACEUTICALS
XYIRIS PHARMACEUTICALS is a Healthcare company. Eye care products and treatments for conditions like Dry Eye, Glaucoma, and ARMD in India. Its Indian entity Xyiris Pharmaceuticals Private Limited reported revenue of ₹35.9 Lakh. XYIRIS PHARMACEUTICALS offers products and services including HYLURIS and XPROST. Its focus areas include Medical Devices, Ophthalmic Products, Eye Drops and Pharmaceuticals.
Company details
XYIRIS PHARMACEUTICALS is recognized for emphasizing vision accessibility through partnerships with ophthalmologists to address sight-threatening diseases. Innovative products for Dry Eye, Glaucoma, and ARMD are provided, aiming to restore patient well-being in India. The companys efforts are noted in treating ocular conditions like Cataract and Ocular Allergy, with a commitment to equal care opportunities. Contacts and distributions are managed from Bhubaneswar, Odisha, as detailed in official records. Overall, treatments are extended via a cohesive approach to eye health.
- SectorsHealthcare
- Email••••••••
- Legal Name Xyiris Pharmaceuticals Pvt Ltd
- Date of Incorporation 27 Mar, 2020
- Jurisdiction Bhubaneswar, Odisha, India
- Indian entity revenue₹35.9 Lakh
FY 2025 · +20% YoY
- Indian entity net profit₹2 Lakh
FY 2025 · 6% margin
- Indian entity EBITDA₹2.9 Lakh
FY 2025 · 8% margin
Associated legal entities of XYIRIS PHARMACEUTICALS
XYIRIS PHARMACEUTICALS operates through Xyiris Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Xyiris Pharmaceuticals Private Limited CIN U24119OR2020PTC032881 | Active | 27 Mar 2020 | Bhubaneswar, Odisha | ₹0.4 Cr | 2 | View details |
Products & Services of XYIRIS PHARMACEUTICALS
XYIRIS PHARMACEUTICALS offers a comprehensive portfolio of products and services, including HYLURIS and XPROST.
Eye drops for Dry Eye are provided as part of treatments for sight-threatening diseases.
Products for Glaucoma are offered in collaboration with ophthalmologists.
Board of directors of Xyiris Pharmaceuticals Private Limited (XYIRIS PHARMACEUTICALS)
Xyiris Pharmaceuticals Private Limited is the primary company behind XYIRIS PHARMACEUTICALS. The board of Xyiris Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Truptirani Mangaraj, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Truptirani Mangaraj DIN 08730763 | Managing Director | 27 Mar 2020 | 6 yrs 6 mo | Xyiris Pharmaceuticals Private Limited |
| Ashok Kumar Subudhi DIN 08730764 | Director | 27 Mar 2020 | 6 yrs 6 mo | Xyiris Pharmaceuticals Private Limited |
Financials of XYIRIS PHARMACEUTICALS
Figures of Xyiris Pharmaceuticals Private Limited, the primary company behind XYIRIS PHARMACEUTICALS, for FY 2025. Revenue was ₹35.9 Lakh (+20% year on year). Net profit was ₹2 Lakh (6% margin). EBITDA was ₹2.9 Lakh (8% margin). Revenue has grown at a compounded annual rate of +40% over three years.
- ₹35.9 LakhRevenue · FY 2025 · +20% YoY
- ₹2 LakhNet profit · 6% margin
- ₹2.9 LakhEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- +40%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Xyiris Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for XYIRIS PHARMACEUTICALS
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about XYIRIS PHARMACEUTICALS
The primary company behind XYIRIS PHARMACEUTICALS, Xyiris Pharmaceuticals Private Limited, reported revenue of ₹35.9 Lakh for FY 2025, up 20% year on year.
XYIRIS PHARMACEUTICALS is recognized for emphasizing vision accessibility through partnerships with ophthalmologists to address sight-threatening diseases. Innovative products for Dry Eye, Glaucoma, and ARMD are provided, aiming to restore patient well-being in India. The companys efforts are noted in treating ocular conditions like Cataract and Ocular Allergy, with a commitment to equal care opportunities. Contacts and distributions are managed from Bhubaneswar, Odisha, as detailed in official records. Overall, treatments are extended via a cohesive approach to eye health.
XYIRIS PHARMACEUTICALS offers HYLURIS and XPROST.
XYIRIS PHARMACEUTICALS operates through Xyiris Pharmaceuticals Private Limited.
The legal entities of XYIRIS PHARMACEUTICALS currently have 2 directors, including Truptirani Mangaraj, Ashok Kumar Subudhi.